VivoSim Labs, INC. (VIVS)
About VivoSim Labs, INC.
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $144.0K
- Net income
- -$2.5M
- Total assets
- $14.7M
- Market cap
- $3.5M
- Operating margin
- -8768.7%
- Net margin
- -10567.2%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $131.0K
- Cost of revenue
- $0
- Operating expenses
- $11.6M
- Operating income
- -$11.5M
- Income tax
- $2.0K
- Net income
- -$13.8M
- EPS (basic)
- $-5.35
- EPS (diluted)
- $-5.35
Balance sheet
- Total assets
- $7.4M
- Current assets
- $6.6M
- Total liabilities
- $8.5M
- Current liabilities
- $2.8M
- Shareholders’ equity
- -$1.1M
Cash flow
- Operating cash flow
- -$10.8M
- Investing cash flow
- $94.0K
- Financing cash flow
- $4.4M
- Net cash flow
- -$6.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $3.5M
- EPS (diluted)
- $-5.35
- Shares outstanding
- 8.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 16, 2011
VivoSim Labs, INC. (VIVS) Stock Price
- Reported a net loss of $2.5M in FY2025.
- Trading 91% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review VivoSim Labs, INC..
Write a review
VivoSim Labs, INC.: frequently asked questions
Is VivoSim Labs, INC. an American company?
VivoSim Labs, INC. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is VivoSim Labs, INC. headquartered?
VivoSim Labs, INC. is headquartered in San Diego, California, United States.
Is VivoSim Labs, INC. publicly traded?
Yes — VivoSim Labs, INC. is a publicly traded company. Its stock trades under the ticker symbol VIVS on the NASDAQ.
What does VivoSim Labs, INC. do?
VivoSim Labs, INC. is an American Pharmaceuticals company in the Health & Beauty sector.
